

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.69860706 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.69860706 |
| 3 | desmosome organization (GO:0002934) | 4.56723452 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 3.79533800 |
| 5 | hemidesmosome assembly (GO:0031581) | 3.75715666 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.65336066 |
| 7 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.59721865 |
| 8 | detection of molecule of bacterial origin (GO:0032490) | 3.46464687 |
| 9 | histone H3-K36 demethylation (GO:0070544) | 3.42918064 |
| 10 | leukocyte aggregation (GO:0070486) | 3.37539718 |
| 11 | positive regulation of granulocyte differentiation (GO:0030854) | 3.35380845 |
| 12 | response to interleukin-15 (GO:0070672) | 3.34769531 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 3.28908478 |
| 14 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.19432999 |
| 15 | regulation of water loss via skin (GO:0033561) | 3.17964709 |
| 16 | establishment of skin barrier (GO:0061436) | 3.14990251 |
| 17 | embryonic process involved in female pregnancy (GO:0060136) | 3.14402218 |
| 18 | tolerance induction (GO:0002507) | 3.13443558 |
| 19 | response to peptidoglycan (GO:0032494) | 3.09333404 |
| 20 | neutrophil activation (GO:0042119) | 3.07839252 |
| 21 | detection of biotic stimulus (GO:0009595) | 3.06911173 |
| 22 | response to laminar fluid shear stress (GO:0034616) | 3.05023324 |
| 23 | regulation of chemokine secretion (GO:0090196) | 3.01957555 |
| 24 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.00920765 |
| 25 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.99342504 |
| 26 | hepatocyte apoptotic process (GO:0097284) | 2.95905340 |
| 27 | regulation of tolerance induction (GO:0002643) | 2.94828726 |
| 28 | definitive hemopoiesis (GO:0060216) | 2.94047121 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 2.93436945 |
| 30 | microglial cell activation (GO:0001774) | 2.84554062 |
| 31 | granulocyte activation (GO:0036230) | 2.80060522 |
| 32 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.78740837 |
| 33 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.75976430 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75894023 |
| 35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.75894023 |
| 36 | cellular response to interleukin-15 (GO:0071350) | 2.75317065 |
| 37 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.74413286 |
| 38 | response to host (GO:0075136) | 2.74413286 |
| 39 | response to host defenses (GO:0052200) | 2.74413286 |
| 40 | negative regulation of interleukin-12 production (GO:0032695) | 2.72826313 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.72450800 |
| 42 | response to host immune response (GO:0052572) | 2.72450800 |
| 43 | macrophage activation (GO:0042116) | 2.72182459 |
| 44 | skin morphogenesis (GO:0043589) | 2.70536253 |
| 45 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.68381542 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.67309482 |
| 47 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.67309482 |
| 48 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.66409788 |
| 49 | B cell receptor signaling pathway (GO:0050853) | 2.64041647 |
| 50 | activated T cell proliferation (GO:0050798) | 2.63012191 |
| 51 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.61565428 |
| 52 | oxygen transport (GO:0015671) | 2.60564110 |
| 53 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.59474292 |
| 54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.57899639 |
| 55 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.57857936 |
| 56 | regulation of regulatory T cell differentiation (GO:0045589) | 2.56789310 |
| 57 | megakaryocyte development (GO:0035855) | 2.56619715 |
| 58 | hemoglobin metabolic process (GO:0020027) | 2.55442483 |
| 59 | myeloid cell development (GO:0061515) | 2.53108281 |
| 60 | negative regulation of stress fiber assembly (GO:0051497) | 2.51348979 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 2.51300479 |
| 62 | T cell migration (GO:0072678) | 2.50293642 |
| 63 | surfactant homeostasis (GO:0043129) | 2.49511976 |
| 64 | keratinocyte proliferation (GO:0043616) | 2.49504260 |
| 65 | establishment of endothelial barrier (GO:0061028) | 2.48122231 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 2.47944692 |
| 67 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.47624940 |
| 68 | positive thymic T cell selection (GO:0045059) | 2.47082122 |
| 69 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.46206063 |
| 70 | regulation of necroptotic process (GO:0060544) | 2.45542881 |
| 71 | regulation of granulocyte differentiation (GO:0030852) | 2.44041099 |
| 72 | regulation of B cell differentiation (GO:0045577) | 2.42824504 |
| 73 | neutrophil mediated immunity (GO:0002446) | 2.42627919 |
| 74 | lymph vessel development (GO:0001945) | 2.42373956 |
| 75 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.42282611 |
| 76 | phospholipid efflux (GO:0033700) | 2.41841171 |
| 77 | erythrocyte maturation (GO:0043249) | 2.41319231 |
| 78 | endodermal cell differentiation (GO:0035987) | 2.41240176 |
| 79 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.41027293 |
| 80 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.40476392 |
| 81 | regulation of mast cell degranulation (GO:0043304) | 2.40385697 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.40329191 |
| 83 | detection of other organism (GO:0098543) | 2.40285437 |
| 84 | erythrocyte development (GO:0048821) | 2.40014617 |
| 85 | negative regulation of adaptive immune response (GO:0002820) | 2.39984451 |
| 86 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.39528920 |
| 87 | keratinocyte differentiation (GO:0030216) | 2.39473750 |
| 88 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.39070064 |
| 89 | negative regulation of interleukin-6 production (GO:0032715) | 2.38935768 |
| 90 | dendritic cell migration (GO:0036336) | 2.37886807 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 2.37196709 |
| 92 | keratinization (GO:0031424) | 2.36962449 |
| 93 | gas transport (GO:0015669) | 2.36203915 |
| 94 | positive regulation of cholesterol efflux (GO:0010875) | 2.35191163 |
| 95 | radial glial cell differentiation (GO:0060019) | 2.33838403 |
| 96 | cell adhesion mediated by integrin (GO:0033627) | 2.33483084 |
| 97 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.33042915 |
| 98 | detection of bacterium (GO:0016045) | 2.32690302 |
| 99 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.32413698 |
| 100 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.30689268 |
| 101 | regulation of leukocyte degranulation (GO:0043300) | 2.30253796 |
| 102 | hypotonic response (GO:0006971) | 2.30231221 |
| 103 | respiratory burst (GO:0045730) | 2.30068020 |
| 104 | regulation of interleukin-8 secretion (GO:2000482) | 2.25616280 |
| 105 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.25524641 |
| 106 | positive regulation of p38MAPK cascade (GO:1900745) | 2.25145153 |
| 107 | mesodermal cell differentiation (GO:0048333) | 2.25108554 |
| 108 | positive regulation of chemokine secretion (GO:0090197) | 2.25092871 |
| 109 | thymic T cell selection (GO:0045061) | 2.24951360 |
| 110 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.22792896 |
| 111 | negative regulation of fatty acid transport (GO:2000192) | 2.22546301 |
| 112 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.22247265 |
| 113 | atrioventricular valve morphogenesis (GO:0003181) | 2.19887942 |
| 114 | positive regulation of sterol transport (GO:0032373) | 2.18034101 |
| 115 | positive regulation of cholesterol transport (GO:0032376) | 2.18034101 |
| 116 | heterotypic cell-cell adhesion (GO:0034113) | 2.17726472 |
| 117 | regulation of phospholipase A2 activity (GO:0032429) | 2.17705687 |
| 118 | regulation of gamma-delta T cell activation (GO:0046643) | 2.16122169 |
| 119 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.15160764 |
| 120 | cellular extravasation (GO:0045123) | 2.14427932 |
| 121 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.13749881 |
| 122 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.13710129 |
| 123 | cell-substrate junction assembly (GO:0007044) | 2.12936841 |
| 124 | apoptotic cell clearance (GO:0043277) | 2.12715466 |
| 125 | gland morphogenesis (GO:0022612) | 2.11605491 |
| 126 | negative T cell selection (GO:0043383) | 2.09430381 |
| 127 | multicellular organismal water homeostasis (GO:0050891) | 2.08024245 |
| 128 | positive T cell selection (GO:0043368) | 2.07558630 |
| 129 | regulation of superoxide anion generation (GO:0032928) | 2.06209952 |
| 130 | positive regulation of tolerance induction (GO:0002645) | 2.06149310 |
| 131 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.06118114 |
| 132 | I-kappaB phosphorylation (GO:0007252) | 2.05846146 |
| 133 | peptide cross-linking (GO:0018149) | 2.05548675 |
| 134 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.05483988 |
| 135 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.05125999 |
| 136 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.04187960 |
| 137 | regulation of integrin activation (GO:0033623) | 2.04141862 |
| 138 | epithelial cell-cell adhesion (GO:0090136) | 2.03302332 |
| 139 | negative regulation of interleukin-8 production (GO:0032717) | 2.03232164 |
| 140 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.03035483 |
| 141 | positive regulation of interferon-alpha production (GO:0032727) | 2.02586510 |
| 142 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.02131000 |
| 143 | germ cell migration (GO:0008354) | 2.02100958 |
| 144 | detection of external biotic stimulus (GO:0098581) | 2.02092788 |
| 145 | negative regulation of protein autophosphorylation (GO:0031953) | 2.01830903 |
| 146 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.01139004 |
| 147 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.01139004 |
| 148 | modulation by symbiont of host immune response (GO:0052553) | 2.01139004 |
| 149 | positive regulation by symbiont of host defense response (GO:0052509) | 2.01139004 |
| 150 | modulation by symbiont of host defense response (GO:0052031) | 2.01139004 |
| 151 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.01139004 |
| 152 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.00748325 |
| 153 | negative regulation of viral entry into host cell (GO:0046597) | 2.00483803 |
| 154 | response to muramyl dipeptide (GO:0032495) | 1.99391966 |
| 155 | hormone catabolic process (GO:0042447) | 1.98922435 |
| 156 | T cell selection (GO:0045058) | 1.98832074 |
| 157 | endothelial cell morphogenesis (GO:0001886) | 1.98776731 |
| 158 | regulation of cholesterol homeostasis (GO:2000188) | 1.98643707 |
| 159 | positive regulation of histone deacetylation (GO:0031065) | 1.97599002 |
| 160 | response to fluid shear stress (GO:0034405) | 1.97213063 |
| 161 | regulation of extracellular matrix disassembly (GO:0010715) | 1.97058734 |
| 162 | interferon-gamma production (GO:0032609) | 1.96969451 |
| 163 | negative thymic T cell selection (GO:0045060) | 1.95407699 |
| 164 | leukocyte cell-cell adhesion (GO:0007159) | 1.95160366 |
| 165 | protein localization to endosome (GO:0036010) | 1.95072423 |
| 166 | epidermal cell differentiation (GO:0009913) | 1.94398564 |
| 167 | plasma lipoprotein particle assembly (GO:0034377) | 1.93718798 |
| 168 | blood vessel endothelial cell migration (GO:0043534) | 1.93138411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.37824510 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.94615820 |
| 3 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.49640668 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.97258042 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.95927179 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.78096312 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.49108020 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.42681148 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.35378612 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.22741944 |
| 11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.06391634 |
| 12 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.05863325 |
| 13 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.03908795 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98000586 |
| 15 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97031182 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.96795701 |
| 17 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.95650941 |
| 18 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.94189117 |
| 19 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.91503257 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89040352 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.84791676 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 1.81629167 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80139426 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.77824402 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.76677519 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75455392 |
| 27 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.75372673 |
| 28 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.75372673 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73145849 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72007781 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.67619084 |
| 32 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.65471283 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.65447712 |
| 34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.64323414 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.62902562 |
| 36 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62639408 |
| 37 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.56163029 |
| 38 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.55302003 |
| 39 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52916206 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52897700 |
| 41 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.52796554 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51729565 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51026459 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.50431906 |
| 45 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49705725 |
| 46 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48964646 |
| 47 | GATA1_19941826_ChIP-Seq_K562_Human | 1.48386469 |
| 48 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.48146766 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48015977 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47122426 |
| 51 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45661119 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44578266 |
| 53 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43798893 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.42926040 |
| 55 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.40388146 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.39040053 |
| 57 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.38353922 |
| 58 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37668935 |
| 59 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.37236825 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36883648 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36536725 |
| 62 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36081689 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35093699 |
| 64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.34381581 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33266903 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31462570 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31277940 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30573193 |
| 69 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30217654 |
| 70 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.28919866 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28299614 |
| 72 | CJUN_26792858_Chip-Seq_BT549_Human | 1.26567047 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25528740 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.25005359 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24083725 |
| 76 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22559030 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21710879 |
| 78 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20183511 |
| 79 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18673169 |
| 80 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17416318 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16174814 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15507006 |
| 83 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14263895 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14174169 |
| 85 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14138842 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13934937 |
| 87 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12969103 |
| 88 | MYB_26560356_Chip-Seq_TH1_Human | 1.12808331 |
| 89 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11862155 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10232021 |
| 91 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09221439 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08877546 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05818497 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05535122 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.05366602 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05120076 |
| 97 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03975462 |
| 98 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03665668 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03124878 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02860357 |
| 101 | MYC_22102868_ChIP-Seq_BL_Human | 1.02382107 |
| 102 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01480998 |
| 103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01435738 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01121133 |
| 105 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00787613 |
| 106 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.00397353 |
| 107 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99958179 |
| 108 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99565653 |
| 109 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99478816 |
| 110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98748095 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98662885 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 0.98612710 |
| 113 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98530218 |
| 114 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98530218 |
| 115 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98530218 |
| 116 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98196994 |
| 117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97940657 |
| 118 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97763004 |
| 119 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97469329 |
| 120 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97328646 |
| 121 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96237801 |
| 122 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95547155 |
| 123 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95450939 |
| 124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94753777 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94673734 |
| 126 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94445485 |
| 127 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94210025 |
| 128 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92103446 |
| 129 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92019164 |
| 130 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.90969436 |
| 131 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90871892 |
| 132 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90110056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 2.95358948 |
| 2 | MP0005275_abnormal_skin_tensile | 2.84554802 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 2.77440613 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 2.71231966 |
| 5 | MP0008260_abnormal_autophagy | 2.30581306 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.28148581 |
| 7 | MP0002060_abnormal_skin_morphology | 2.24687891 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.17932381 |
| 9 | MP0003453_abnormal_keratinocyte_physiol | 2.16737966 |
| 10 | MP0004947_skin_inflammation | 2.14465333 |
| 11 | MP0003941_abnormal_skin_development | 2.14396183 |
| 12 | MP0005501_abnormal_skin_physiology | 2.08290609 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.06853592 |
| 14 | MP0003566_abnormal_cell_adhesion | 1.95182904 |
| 15 | MP0001851_eye_inflammation | 1.84155910 |
| 16 | MP0002166_altered_tumor_susceptibility | 1.80569864 |
| 17 | MP0001216_abnormal_epidermal_layer | 1.73297676 |
| 18 | MP0004883_abnormal_blood_vessel | 1.70712480 |
| 19 | MP0002254_reproductive_system_inflammat | 1.68735437 |
| 20 | MP0002398_abnormal_bone_marrow | 1.66430975 |
| 21 | MP0003866_abnormal_defecation | 1.66024732 |
| 22 | MP0002009_preneoplasia | 1.64289772 |
| 23 | MP0006054_spinal_hemorrhage | 1.59637856 |
| 24 | MP0010678_abnormal_skin_adnexa | 1.58763315 |
| 25 | MP0002006_tumorigenesis | 1.57600353 |
| 26 | MP0005023_abnormal_wound_healing | 1.55298936 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.54586926 |
| 28 | MP0000383_abnormal_hair_follicle | 1.53744822 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.53552695 |
| 30 | MP0003436_decreased_susceptibility_to | 1.51089976 |
| 31 | MP0005360_urolithiasis | 1.49839560 |
| 32 | MP0002098_abnormal_vibrissa_morphology | 1.49218421 |
| 33 | MP0005164_abnormal_response_to | 1.47180424 |
| 34 | MP0000716_abnormal_immune_system | 1.44125000 |
| 35 | MP0000685_abnormal_immune_system | 1.40685886 |
| 36 | MP0005451_abnormal_body_composition | 1.38301131 |
| 37 | MP0009384_cardiac_valve_regurgitation | 1.38267888 |
| 38 | MP0002722_abnormal_immune_system | 1.37591118 |
| 39 | MP0004147_increased_porphyrin_level | 1.34822271 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.34794403 |
| 41 | MP0003252_abnormal_bile_duct | 1.34076557 |
| 42 | MP0003279_aneurysm | 1.33297480 |
| 43 | MP0009278_abnormal_bone_marrow | 1.32248539 |
| 44 | MP0004381_abnormal_hair_follicle | 1.29083988 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.28692566 |
| 46 | MP0001873_stomach_inflammation | 1.28137097 |
| 47 | MP0003724_increased_susceptibility_to | 1.28108074 |
| 48 | MP0000377_abnormal_hair_follicle | 1.27605933 |
| 49 | MP0010771_integument_phenotype | 1.26965068 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.26940485 |
| 51 | MP0004272_abnormal_basement_membrane | 1.23930735 |
| 52 | MP0009053_abnormal_anal_canal | 1.23839651 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.22372533 |
| 54 | MP0001191_abnormal_skin_condition | 1.22258411 |
| 55 | MP0005085_abnormal_gallbladder_physiolo | 1.21041655 |
| 56 | MP0002429_abnormal_blood_cell | 1.20222408 |
| 57 | MP0001666_abnormal_nutrient_absorption | 1.19375562 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.19339091 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.19082165 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.18680223 |
| 61 | MP0005083_abnormal_biliary_tract | 1.17759914 |
| 62 | MP0009931_abnormal_skin_appearance | 1.16638981 |
| 63 | MP0005387_immune_system_phenotype | 1.16588319 |
| 64 | MP0001790_abnormal_immune_system | 1.16588319 |
| 65 | MP0001243_abnormal_dermal_layer | 1.15244557 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.14856014 |
| 67 | MP0000579_abnormal_nail_morphology | 1.12105136 |
| 68 | MP0000467_abnormal_esophagus_morphology | 1.11309529 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.10036108 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.09893668 |
| 71 | MP0005310_abnormal_salivary_gland | 1.09864577 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 1.09397014 |
| 73 | MP0003828_pulmonary_edema | 1.07860633 |
| 74 | MP0001958_emphysema | 1.07427062 |
| 75 | MP0001849_ear_inflammation | 1.06944276 |
| 76 | MP0001545_abnormal_hematopoietic_system | 1.06693747 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 1.06693747 |
| 78 | MP0005409_darkened_coat_color | 1.06213986 |
| 79 | MP0000249_abnormal_blood_vessel | 1.04701331 |
| 80 | MP0000858_altered_metastatic_potential | 1.03485477 |
| 81 | MP0009785_altered_susceptibility_to | 1.03255002 |
| 82 | MP0008004_abnormal_stomach_pH | 1.02881554 |
| 83 | MP0001800_abnormal_humoral_immune | 1.02776057 |
| 84 | MP0001835_abnormal_antigen_presentation | 1.02725699 |
| 85 | MP0000490_abnormal_crypts_of | 1.02586198 |
| 86 | * MP0005076_abnormal_cell_differentiation | 1.02021240 |
| 87 | MP0003303_peritoneal_inflammation | 1.01648927 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 1.01288816 |
| 89 | MP0008469_abnormal_protein_level | 1.00679517 |
| 90 | MP0005025_abnormal_response_to | 1.00223844 |
| 91 | MP0002419_abnormal_innate_immunity | 0.99414181 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.99156521 |
| 93 | MP0001533_abnormal_skeleton_physiology | 0.98436866 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.97874436 |
| 95 | MP0002405_respiratory_system_inflammati | 0.97823326 |
| 96 | MP0003448_altered_tumor_morphology | 0.97697653 |
| 97 | MP0002139_abnormal_hepatobiliary_system | 0.97493273 |
| 98 | MP0002452_abnormal_antigen_presenting | 0.97351337 |
| 99 | MP0009764_decreased_sensitivity_to | 0.96825842 |
| 100 | MP0004130_abnormal_muscle_cell | 0.96178704 |
| 101 | MP0002148_abnormal_hypersensitivity_rea | 0.94737822 |
| 102 | MP0005000_abnormal_immune_tolerance | 0.94158614 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.93757455 |
| 104 | MP0005671_abnormal_response_to | 0.93214158 |
| 105 | MP0001346_abnormal_lacrimal_gland | 0.91716179 |
| 106 | MP0002933_joint_inflammation | 0.91546236 |
| 107 | MP0005464_abnormal_platelet_physiology | 0.91523781 |
| 108 | MP0005166_decreased_susceptibility_to | 0.91440455 |
| 109 | MP0002132_abnormal_respiratory_system | 0.90347974 |
| 110 | MP0000767_abnormal_smooth_muscle | 0.90011695 |
| 111 | MP0006082_CNS_inflammation | 0.89299374 |
| 112 | MP0003091_abnormal_cell_migration | 0.87335860 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.86737564 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.86544757 |
| 115 | MP0005367_renal/urinary_system_phenotyp | 0.86258949 |
| 116 | MP0000516_abnormal_urinary_system | 0.86258949 |
| 117 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85631962 |
| 118 | MP0002396_abnormal_hematopoietic_system | 0.84837187 |
| 119 | MP0002420_abnormal_adaptive_immunity | 0.83856808 |
| 120 | MP0001819_abnormal_immune_cell | 0.83777617 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.82822306 |
| 122 | MP0000647_abnormal_sebaceous_gland | 0.81716717 |
| 123 | MP0002723_abnormal_immune_serum | 0.81709775 |
| 124 | MP0009763_increased_sensitivity_to | 0.80343556 |
| 125 | MP0003045_fibrosis | 0.80258835 |
| 126 | MP0000477_abnormal_intestine_morphology | 0.80044213 |
| 127 | MP0001663_abnormal_digestive_system | 0.77934499 |
| 128 | MP0004484_altered_response_of | 0.77787285 |
| 129 | MP0000609_abnormal_liver_physiology | 0.76293366 |
| 130 | MP0005365_abnormal_bile_salt | 0.76095117 |
| 131 | MP0003690_abnormal_glial_cell | 0.75425385 |
| 132 | MP0009115_abnormal_fat_cell | 0.74751300 |
| 133 | MP0005666_abnormal_adipose_tissue | 0.74608774 |
| 134 | MP0003075_altered_response_to | 0.70098336 |
| 135 | MP0001853_heart_inflammation | 0.69119800 |
| 136 | MP0005388_respiratory_system_phenotype | 0.67238875 |
| 137 | MP0002133_abnormal_respiratory_system | 0.67238875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.16825807 |
| 2 | Gastrointestinal infarctions (HP:0005244) | 3.83228706 |
| 3 | Pustule (HP:0200039) | 3.61421390 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 3.56608591 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.39803725 |
| 6 | Optic neuritis (HP:0100653) | 3.34879272 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 3.34879272 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.28951268 |
| 9 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.26289628 |
| 10 | Epistaxis (HP:0000421) | 3.19433367 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.15711253 |
| 12 | Recurrent skin infections (HP:0001581) | 3.06435316 |
| 13 | Keratoconjunctivitis sicca (HP:0001097) | 3.05831897 |
| 14 | Stomatitis (HP:0010280) | 3.02909037 |
| 15 | Atrophic scars (HP:0001075) | 2.99681293 |
| 16 | Onycholysis (HP:0001806) | 2.95072205 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.92338467 |
| 18 | Eczematoid dermatitis (HP:0000976) | 2.88363312 |
| 19 | Keratoconjunctivitis (HP:0001096) | 2.84157247 |
| 20 | Increased IgE level (HP:0003212) | 2.81603918 |
| 21 | Microcytic anemia (HP:0001935) | 2.78619253 |
| 22 | Plantar hyperkeratosis (HP:0007556) | 2.68044469 |
| 23 | Thick nail (HP:0001805) | 2.67630546 |
| 24 | Milia (HP:0001056) | 2.65205167 |
| 25 | Premature rupture of membranes (HP:0001788) | 2.63016945 |
| 26 | Aortic aneurysm (HP:0004942) | 2.60915024 |
| 27 | Hematochezia (HP:0002573) | 2.59449526 |
| 28 | Osteolytic defects of the hand bones (HP:0009699) | 2.54368469 |
| 29 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.54368469 |
| 30 | Woolly hair (HP:0002224) | 2.54358346 |
| 31 | Lip pit (HP:0100267) | 2.53087656 |
| 32 | Protrusio acetabuli (HP:0003179) | 2.53035428 |
| 33 | Vasculitis (HP:0002633) | 2.52186995 |
| 34 | Aortic dissection (HP:0002647) | 2.48521760 |
| 35 | Autoimmune hemolytic anemia (HP:0001890) | 2.46479984 |
| 36 | Alopecia of scalp (HP:0002293) | 2.46088757 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 2.46076512 |
| 38 | Encephalitis (HP:0002383) | 2.45609091 |
| 39 | Fragile skin (HP:0001030) | 2.43729503 |
| 40 | Poikilocytosis (HP:0004447) | 2.39406622 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.37322080 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.37322080 |
| 43 | Meningitis (HP:0001287) | 2.36559832 |
| 44 | Cerebral aneurysm (HP:0004944) | 2.34862665 |
| 45 | Palmoplantar hyperkeratosis (HP:0000972) | 2.33462009 |
| 46 | Chest pain (HP:0100749) | 2.33336958 |
| 47 | Slow saccadic eye movements (HP:0000514) | 2.30705845 |
| 48 | Recurrent viral infections (HP:0004429) | 2.27370727 |
| 49 | Hemoptysis (HP:0002105) | 2.26620120 |
| 50 | Papillary thyroid carcinoma (HP:0002895) | 2.25153594 |
| 51 | Rectal prolapse (HP:0002035) | 2.24956474 |
| 52 | Arterial thrombosis (HP:0004420) | 2.24372834 |
| 53 | Myocardial infarction (HP:0001658) | 2.24022905 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.22939008 |
| 55 | Leukocytosis (HP:0001974) | 2.22615208 |
| 56 | Menorrhagia (HP:0000132) | 2.22428257 |
| 57 | Palmar hyperkeratosis (HP:0010765) | 2.22225289 |
| 58 | Peritonitis (HP:0002586) | 2.21577795 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.21133737 |
| 60 | Abnormality of T cells (HP:0002843) | 2.20984985 |
| 61 | Broad metatarsal (HP:0001783) | 2.19461001 |
| 62 | Esophageal varix (HP:0002040) | 2.17882033 |
| 63 | Abnormality of nail color (HP:0100643) | 2.15852163 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.14870554 |
| 65 | Ectropion (HP:0000656) | 2.09945922 |
| 66 | Obstructive lung disease (HP:0006536) | 2.09898449 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.09898449 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 2.09342604 |
| 69 | Periodontitis (HP:0000704) | 2.09064415 |
| 70 | Mitral valve prolapse (HP:0001634) | 2.08863616 |
| 71 | Petechiae (HP:0000967) | 2.07418160 |
| 72 | Pulmonary embolism (HP:0002204) | 2.07080074 |
| 73 | Osteomyelitis (HP:0002754) | 2.06083528 |
| 74 | Shallow orbits (HP:0000586) | 2.05569535 |
| 75 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.05361133 |
| 76 | Ileus (HP:0002595) | 2.03266947 |
| 77 | Abnormal platelet volume (HP:0011876) | 2.02801580 |
| 78 | Gastrointestinal inflammation (HP:0004386) | 2.02230202 |
| 79 | Increased mean platelet volume (HP:0011877) | 1.99966707 |
| 80 | Cellulitis (HP:0100658) | 1.98749003 |
| 81 | Acanthocytosis (HP:0001927) | 1.98002582 |
| 82 | Anorexia (HP:0002039) | 1.96879549 |
| 83 | Hypotrichosis (HP:0001006) | 1.95748213 |
| 84 | Purpura (HP:0000979) | 1.94315445 |
| 85 | Toxemia of pregnancy (HP:0100603) | 1.92523375 |
| 86 | Increased connective tissue (HP:0009025) | 1.91166718 |
| 87 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90633989 |
| 88 | Fragile nails (HP:0001808) | 1.89465435 |
| 89 | Dilatation of the ascending aorta (HP:0005111) | 1.86951866 |
| 90 | Hypergammaglobulinemia (HP:0010702) | 1.86886951 |
| 91 | Parakeratosis (HP:0001036) | 1.86605620 |
| 92 | Systemic lupus erythematosus (HP:0002725) | 1.85980519 |
| 93 | Impaired platelet aggregation (HP:0003540) | 1.83762778 |
| 94 | Abnormal platelet function (HP:0011869) | 1.83762778 |
| 95 | Abnormality of T cell number (HP:0011839) | 1.83585847 |
| 96 | Abnormality of T cell physiology (HP:0011840) | 1.82748099 |
| 97 | Abnormality of the fingertips (HP:0001211) | 1.82686564 |
| 98 | Viral hepatitis (HP:0006562) | 1.82359814 |
| 99 | Abnormality of the common coagulation pathway (HP:0010990) | 1.81312003 |
| 100 | Increased CSF protein (HP:0002922) | 1.80829604 |
| 101 | Thrombophlebitis (HP:0004418) | 1.80672562 |
| 102 | T lymphocytopenia (HP:0005403) | 1.79662288 |
| 103 | Coarse hair (HP:0002208) | 1.78824239 |
| 104 | Flat acetabular roof (HP:0003180) | 1.78033072 |
| 105 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.77776236 |
| 106 | Hemorrhage of the eye (HP:0011885) | 1.77056452 |
| 107 | Ankle contracture (HP:0006466) | 1.76367371 |
| 108 | Keratitis (HP:0000491) | 1.75568805 |
| 109 | Abnormal blistering of the skin (HP:0008066) | 1.75123093 |
| 110 | Colitis (HP:0002583) | 1.74593080 |
| 111 | Urticaria (HP:0001025) | 1.74567865 |
| 112 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.74485962 |
| 113 | Xanthomatosis (HP:0000991) | 1.73499722 |
| 114 | Recurrent abscess formation (HP:0002722) | 1.73046210 |
| 115 | Abnormality of the nasal septum (HP:0000419) | 1.72837175 |
| 116 | Deep venous thrombosis (HP:0002625) | 1.72369484 |
| 117 | Vascular tortuosity (HP:0004948) | 1.71821743 |
| 118 | Episodic fever (HP:0001954) | 1.71539548 |
| 119 | Granulocytopenia (HP:0001913) | 1.71316926 |
| 120 | Arterial tortuosity (HP:0005116) | 1.70926731 |
| 121 | Erythema (HP:0010783) | 1.70086304 |
| 122 | Verrucae (HP:0200043) | 1.68563907 |
| 123 | Papilloma (HP:0012740) | 1.68563907 |
| 124 | Hypochromic microcytic anemia (HP:0004840) | 1.68521944 |
| 125 | Gingivitis (HP:0000230) | 1.68346275 |
| 126 | Panhypogammaglobulinemia (HP:0003139) | 1.68009006 |
| 127 | Hyperactive renin-angiotensin system (HP:0000841) | 1.67715729 |
| 128 | Amyloidosis (HP:0011034) | 1.67489857 |
| 129 | Abnormality of the gastric mucosa (HP:0004295) | 1.66997741 |
| 130 | Ureteral obstruction (HP:0006000) | 1.66876798 |
| 131 | Urethral obstruction (HP:0000796) | 1.66703142 |
| 132 | Abnormal foot bone ossification (HP:0010675) | 1.66491363 |
| 133 | Joint swelling (HP:0001386) | 1.66264941 |
| 134 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.66153917 |
| 135 | Hyperlipoproteinemia (HP:0010980) | 1.65930291 |
| 136 | Ulnar bowing (HP:0003031) | 1.65353063 |
| 137 | Advanced eruption of teeth (HP:0006288) | 1.64994938 |
| 138 | Cupped ribs (HP:0000887) | 1.64773159 |
| 139 | Cervical subluxation (HP:0003308) | 1.64316534 |
| 140 | Gangrene (HP:0100758) | 1.64181453 |
| 141 | Ureteral stenosis (HP:0000071) | 1.64108905 |
| 142 | Ventricular tachycardia (HP:0004756) | 1.64037430 |
| 143 | Gingival bleeding (HP:0000225) | 1.63980438 |
| 144 | Subacute progressive viral hepatitis (HP:0006572) | 1.63927259 |
| 145 | Polycythemia (HP:0001901) | 1.63510998 |
| 146 | Nephritis (HP:0000123) | 1.62846159 |
| 147 | Distal lower limb muscle weakness (HP:0009053) | 1.62524296 |
| 148 | Aplasia cutis congenita (HP:0001057) | 1.61147435 |
| 149 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.61108905 |
| 150 | Pili torti (HP:0003777) | 1.60482713 |
| 151 | Abnormal hemoglobin (HP:0011902) | 1.60130458 |
| 152 | Hypochromic anemia (HP:0001931) | 1.59372231 |
| 153 | Disproportionate tall stature (HP:0001519) | 1.59104840 |
| 154 | Pruritus (HP:0000989) | 1.58880256 |
| 155 | Skin ulcer (HP:0200042) | 1.58873300 |
| 156 | Abnormality of complement system (HP:0005339) | 1.58513496 |
| 157 | Nonimmune hydrops fetalis (HP:0001790) | 1.58243523 |
| 158 | Congenital, generalized hypertrichosis (HP:0004540) | 1.57409243 |
| 159 | Orchitis (HP:0100796) | 1.55471389 |
| 160 | Prolonged bleeding time (HP:0003010) | 1.54786301 |
| 161 | Aneurysm (HP:0002617) | 1.54739962 |
| 162 | Spinal cord lesions (HP:0100561) | 1.54055806 |
| 163 | Syringomyelia (HP:0003396) | 1.54055806 |
| 164 | Complement deficiency (HP:0004431) | 1.53887253 |
| 165 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.53374139 |
| 166 | Myositis (HP:0100614) | 1.52521484 |
| 167 | Recurrent fungal infections (HP:0002841) | 1.52293018 |
| 168 | Hepatocellular carcinoma (HP:0001402) | 1.51534378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.35205127 |
| 2 | PRPF4B | 3.13386574 |
| 3 | STK10 | 2.76387585 |
| 4 | TGFBR2 | 2.67484932 |
| 5 | ERN1 | 2.47723801 |
| 6 | MST4 | 2.31953196 |
| 7 | MAP3K14 | 2.11728259 |
| 8 | MST1R | 2.05585069 |
| 9 | FES | 1.98932572 |
| 10 | LATS1 | 1.87155313 |
| 11 | CDK12 | 1.86682801 |
| 12 | FRK | 1.83612586 |
| 13 | FGFR4 | 1.82296919 |
| 14 | SIK3 | 1.78811244 |
| 15 | EPHA2 | 1.72040195 |
| 16 | SIK1 | 1.71889065 |
| 17 | MAP3K3 | 1.69700618 |
| 18 | YES1 | 1.69403943 |
| 19 | MAP4K1 | 1.69375672 |
| 20 | TRIB3 | 1.66789621 |
| 21 | TYK2 | 1.63027779 |
| 22 | EPHB1 | 1.62111240 |
| 23 | IKBKE | 1.59891269 |
| 24 | PTK6 | 1.52699385 |
| 25 | BTK | 1.51889679 |
| 26 | TTN | 1.50422460 |
| 27 | TRPM7 | 1.49927093 |
| 28 | RIPK1 | 1.47248819 |
| 29 | CSK | 1.44876048 |
| 30 | FGFR3 | 1.43782625 |
| 31 | LRRK2 | 1.43373760 |
| 32 | EPHB2 | 1.43024443 |
| 33 | MAP3K10 | 1.43015825 |
| 34 | TBK1 | 1.38349671 |
| 35 | CDK6 | 1.35566412 |
| 36 | JAK1 | 1.31888192 |
| 37 | ITK | 1.31383647 |
| 38 | KDR | 1.30139733 |
| 39 | BMPR2 | 1.29118586 |
| 40 | JAK3 | 1.28233908 |
| 41 | TXK | 1.26995263 |
| 42 | SYK | 1.26287651 |
| 43 | BLK | 1.26078695 |
| 44 | FGR | 1.24653397 |
| 45 | SGK2 | 1.24105262 |
| 46 | NUAK1 | 1.22660628 |
| 47 | MARK3 | 1.21923862 |
| 48 | STK3 | 1.21790218 |
| 49 | EPHA3 | 1.21355726 |
| 50 | MAP3K1 | 1.21153768 |
| 51 | NLK | 1.20878016 |
| 52 | RPS6KA4 | 1.20501527 |
| 53 | CAMK1D | 1.19897489 |
| 54 | SGK3 | 1.19195387 |
| 55 | KSR2 | 1.17048421 |
| 56 | PKN2 | 1.15779900 |
| 57 | GRK6 | 1.15590859 |
| 58 | MARK2 | 1.14894893 |
| 59 | HIPK2 | 1.13154648 |
| 60 | AKT3 | 1.10483030 |
| 61 | STK4 | 1.09492065 |
| 62 | IRAK1 | 1.08830362 |
| 63 | IKBKB | 1.06549691 |
| 64 | MAPKAPK3 | 1.01943544 |
| 65 | WNK1 | 1.00095416 |
| 66 | FGFR2 | 0.99679308 |
| 67 | CLK1 | 0.99398141 |
| 68 | CHUK | 0.99374650 |
| 69 | RPS6KB2 | 0.99342314 |
| 70 | DMPK | 0.97767699 |
| 71 | ACVR1B | 0.97166837 |
| 72 | TAOK2 | 0.96683399 |
| 73 | DDR2 | 0.95162006 |
| 74 | MET | 0.94873604 |
| 75 | MAP3K6 | 0.94574181 |
| 76 | CAMKK2 | 0.94418384 |
| 77 | PIM1 | 0.94321072 |
| 78 | FER | 0.94158915 |
| 79 | LYN | 0.93435134 |
| 80 | MAP2K3 | 0.93330224 |
| 81 | EEF2K | 0.92582217 |
| 82 | PTK2 | 0.92117185 |
| 83 | TNK2 | 0.90460529 |
| 84 | MAP2K2 | 0.87262643 |
| 85 | PTK2B | 0.86781172 |
| 86 | PIK3CA | 0.86102181 |
| 87 | PDGFRA | 0.85092119 |
| 88 | PDGFRB | 0.83605035 |
| 89 | IRAK3 | 0.82513839 |
| 90 | ZAP70 | 0.80341273 |
| 91 | MELK | 0.79659274 |
| 92 | MAP3K7 | 0.78772176 |
| 93 | STK24 | 0.78193562 |
| 94 | TEC | 0.77537105 |
| 95 | DYRK1B | 0.76354725 |
| 96 | BMX | 0.74710194 |
| 97 | PAK4 | 0.74159066 |
| 98 | FLT3 | 0.73957534 |
| 99 | PDK1 | 0.70964531 |
| 100 | RET | 0.70255475 |
| 101 | JAK2 | 0.68943106 |
| 102 | ERBB2 | 0.68192436 |
| 103 | SGK223 | 0.67849289 |
| 104 | SGK494 | 0.67849289 |
| 105 | STK38 | 0.66783988 |
| 106 | IRAK4 | 0.66645549 |
| 107 | HCK | 0.66556798 |
| 108 | MAP3K13 | 0.66426713 |
| 109 | MAPK12 | 0.65946302 |
| 110 | IRAK2 | 0.65050885 |
| 111 | TIE1 | 0.64068419 |
| 112 | MAPK11 | 0.63778379 |
| 113 | STK11 | 0.63541524 |
| 114 | LCK | 0.63517016 |
| 115 | MAPKAPK2 | 0.63060126 |
| 116 | NEK9 | 0.60776126 |
| 117 | FGFR1 | 0.60373319 |
| 118 | CDK9 | 0.58412857 |
| 119 | MAP3K2 | 0.58176208 |
| 120 | KSR1 | 0.55551523 |
| 121 | MAP3K5 | 0.55490462 |
| 122 | PRKAA2 | 0.55336499 |
| 123 | PRKG2 | 0.54650793 |
| 124 | MAP3K8 | 0.54595733 |
| 125 | CDC42BPA | 0.53847643 |
| 126 | PDPK1 | 0.52261572 |
| 127 | MTOR | 0.50678317 |
| 128 | PRKD2 | 0.50472145 |
| 129 | CSF1R | 0.49398894 |
| 130 | TAOK3 | 0.47919441 |
| 131 | PRKCQ | 0.46917648 |
| 132 | PRKD1 | 0.46630579 |
| 133 | TYRO3 | 0.46485015 |
| 134 | MAPK7 | 0.46244955 |
| 135 | BRD4 | 0.45988454 |
| 136 | CAMK1G | 0.44487943 |
| 137 | GSK3A | 0.44464893 |
| 138 | TAOK1 | 0.43509517 |
| 139 | ABL1 | 0.43053823 |
| 140 | PIK3CG | 0.43048650 |
| 141 | LMTK2 | 0.42623610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.30185689 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.95137309 |
| 3 | Adherens junction_Homo sapiens_hsa04520 | 1.84030906 |
| 4 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.77345680 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71369672 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63552491 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.61850562 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.61044053 |
| 9 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59090055 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.58771269 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51943256 |
| 12 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.50724059 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46362300 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.45721119 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44164680 |
| 16 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.42850947 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41159066 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38684611 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34881495 |
| 20 | ABC transporters_Homo sapiens_hsa02010 | 1.34525894 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33146340 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32911582 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.29267780 |
| 24 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.28338855 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.28334198 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28034428 |
| 27 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.27831389 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26505665 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24640472 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23438834 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.22378196 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17605518 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17541919 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15497649 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.15493039 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.15009969 |
| 37 | Focal adhesion_Homo sapiens_hsa04510 | 1.12477330 |
| 38 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.11149139 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11046426 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 1.10818873 |
| 41 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.10799471 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.10506071 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09866320 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08935155 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 1.07819176 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.07119373 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06752990 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05997760 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05007205 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03077754 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02801689 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 1.02034346 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.02020808 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01795935 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 1.01384445 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00301927 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.97077500 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96950721 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95939122 |
| 60 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95829068 |
| 61 | Prostate cancer_Homo sapiens_hsa05215 | 0.95741118 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95185649 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94803575 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92414465 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91830071 |
| 66 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91643027 |
| 67 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91258063 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.90598016 |
| 69 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.90173554 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89574668 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.89460638 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.88999361 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.87388510 |
| 74 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.87270065 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86351614 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.86219864 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83960359 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83124792 |
| 79 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.82880471 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82501849 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82457780 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82417637 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.80545839 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79851936 |
| 85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79743612 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77849951 |
| 87 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77666495 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76977666 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76753489 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76655994 |
| 91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76614835 |
| 92 | Tuberculosis_Homo sapiens_hsa05152 | 0.75797288 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75554541 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.74444838 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74146769 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73305664 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73196997 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72372829 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71146075 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70509624 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70233816 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70169609 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69871132 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69406463 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.68830280 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.68500662 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67316612 |
| 108 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66925324 |
| 109 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.66815952 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66771737 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66021752 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.65701018 |
| 113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65480671 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65198215 |
| 115 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64767747 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63230643 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62924239 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62603349 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62474002 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61258375 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.59174919 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58600408 |
| 123 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57151171 |
| 124 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.57107833 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57100116 |
| 126 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56650503 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56306254 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.55927547 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55034381 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.54267882 |
| 131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53437217 |
| 132 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52901962 |
| 133 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52752856 |
| 134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52537229 |
| 135 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52466448 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52254112 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51598068 |
| 138 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50345528 |
| 139 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49514687 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48800441 |

